Medicare does not currently cover Wegovy, but coverage rules are changing

As of 2024, Medicare Part D does not pay for Wegovy (semaglutide) or other weight-loss medications, even if your doctor prescribes it. This is because Medicare has a long-standing rule that excludes drugs used only for weight loss. However, the landscape is shifting. A new law passed in 2023 allows Medicare to negotiate drug prices starting in 2026, and weight-loss medications are on the list of drugs that could be included in those negotiations. Some private Medicare Advantage plans have begun covering Wegovy under specific conditions, so your coverage depends on which plan you have and when you enrolled.

The cost of Wegovy without insurance is significant — a month's supply typically ranges from $900 to $1,500 depending on the dose. If you are considering this medication, you will need to understand your current coverage, explore what your specific plan offers, and know what questions to ask your doctor and your plan.

Key Takeaways

  • Original Medicare (Part A and Part B) does not cover weight-loss drugs under any circumstances.
  • Some Medicare Advantage plans have started covering Wegovy, but only for people with type 2 diabetes or heart disease, not for weight loss alone.
  • You must contact your specific Medicare Advantage plan to learn whether Wegovy is covered under your policy and what conditions explore.
  • If your plan does not cover Wegovy, manufacturer discount programs and patient information programs can reduce the cost to $25 to $250 per month.
  • Talk to your doctor about whether Wegovy is medically necessary for your condition, because coverage decisions often hinge on diagnosis, not weight alone.

Why Medicare does not cover weight-loss drugs

Medicare's exclusion of weight-loss medications has been in place for decades. The rule states that Medicare will not pay for drugs used solely to treat obesity. The reasoning behind this policy is that obesity itself is not classified as a disease in Medicare's framework — it is considered a risk factor for other diseases like heart disease and diabetes.

This distinction matters legally and practically. If a drug's only approved use is weight loss, Medicare will not cover it. Wegovy is approved by the FDA specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition. That approval is for weight loss, which is why the original Medicare exclusion applies.

However, the rule has a narrow exception: if a weight-loss drug is approved for a different condition — such as diabetes — and your doctor prescribes it for that condition, Medicare may cover it. This is why some people with type 2 diabetes have been able to access semaglutide through Medicare, but under the brand name Ozempic (which is approved for diabetes), not Wegovy.

What Medicare Advantage plans are doing now

Medicare Advantage plans (Part C) operate differently from original Medicare. They are run by private insurance companies and can set their own coverage rules within federal guidelines. Some Advantage plans have begun covering Wegovy, but with strict limits.

The most common coverage pattern is: Wegovy is covered only for people with type 2 diabetes or established cardiovascular disease, not for weight loss alone. Even then, plans typically require that you try other weight-loss methods first, such as diet and exercise programs or other medications. Some plans require your doctor to document that you have a BMI above a certain threshold (often 30 or higher) plus a weight-related condition.

Coverage also varies by plan and by state. Two people with Medicare Advantage in the same state may have different coverage if they are enrolled in different plans. This is why you cannot assume your neighbor's coverage applies to you.

How to find out what your plan covers

The only way to know whether your plan covers Wegovy is to contact your Medicare Advantage plan directly. Call the customer service number on the back of your insurance card. Have your member ID ready.

Ask these specific questions:

  • Does your plan cover Wegovy or semaglutide for weight loss?
  • If yes, what conditions must I have (such as type 2 diabetes or heart disease)?
  • What is the cost to me — the copay, coinsurance, or deductible?
  • Does your plan require prior authorization from my doctor before the prescription is filled?
  • Does your plan require me to try other treatments first?
  • Is there a quantity limit — for example, a limit on how many pens per month?

Write down the answers and the date and name of the representative you spoke with. If your plan says no, ask whether there is an appeals process if your doctor believes the medication is medically necessary.

If you have original Medicare (not an Advantage plan), the answer is no — original Medicare does not cover Wegovy under any circumstances. Your only options are to pay out of pocket or explore the cost-reduction programs described below.

What to expect if your plan does cover it

If your Medicare Advantage plan does cover Wegovy, your out-of-pocket cost depends on your plan's structure. Some plans charge a copay per prescription (often $35 to $75). Others use coinsurance, meaning you pay a percentage of the drug's cost. A few plans cover it with no copay if you meet their medical criteria.

Most plans that cover Wegovy require prior authorization. This means your doctor must submit paperwork to the plan explaining why you need the medication, and the plan must approve it before the pharmacy will fill your prescription. This process usually takes 3 to 5 business days but can take longer if the plan requests additional information from your doctor.

Once approved, you will pick up your prescription at a pharmacy that participates in your plan's network. Wegovy comes as a pre-filled injection pen that you use once a week. Your doctor will tell you which dose to start with and how to increase it over time.

Cost-reduction options if your plan does not cover Wegovy

If your plan does not cover Wegovy, you have several options to reduce the cost.

Novo Nordisk Patient information Program: Novo Nordisk, the manufacturer of Wegovy, offers a program that can reduce your cost to as low as $25 per month if your household income is below a certain threshold (which varies by state). You can explore through their website or ask your doctor's office to help you explore. The process takes about 10 minutes and requires proof of income.

Manufacturer coupon or savings card: Novo Nordisk also offers a savings card that can reduce your copay to $250 per month for people who have insurance but whose plan does not cover the drug or charges a high copay. This card is available through your pharmacy or your doctor's office.

GoodRx or similar discount programs: Websites like GoodRx, SingleCare, and RxSaver let you compare prices at different pharmacies and sometimes offer discounts. Prices vary widely by location and pharmacy, so it is worth checking multiple sources. Discounts through these programs typically range from $500 to $1,200 per month depending on the dose and location.

Ask your doctor about alternatives: If cost is a barrier, talk to your doctor about whether other weight-loss medications might be covered by your plan or might be less expensive. Some older medications like phentermine are much cheaper and may be covered.

What might change in the future

The Inflation Reduction Act, passed in 2023, allows Medicare to negotiate the prices of certain drugs starting in 2026. Weight-loss medications are on the preliminary list of drugs that could be negotiated. If Wegovy is included in those negotiations, its price could drop, which might make it more likely that Medicare Advantage plans will cover it.

Additionally, some states and advocacy groups are pushing for Medicare to reconsider its exclusion of weight-loss drugs, arguing that obesity is a disease and should be treated like one. No change has been made yet, but this conversation is ongoing in Congress and within Medicare.

For now, coverage remains limited and plan-specific. Check back with your plan annually, because coverage policies can change from year to year.

Questions to ask your doctor

Before pursuing Wegovy, have a conversation with your doctor about whether it is the right choice for you. Here are the questions to ask:

  • Do you think Wegovy would help my health, and why?
  • What weight loss should I expect, and over what timeframe?
  • What are the side effects, and which ones should I report to you when ready?
  • If my Medicare plan requires that I try other treatments first, what should those be?
  • If my plan denies coverage, will you help me appeal the decision or provide documentation for a patient information program?
  • How long would I need to take this medication, and what happens if I stop?

Frequently Asked Questions

Can I use Ozempic instead of Wegovy if my doctor prescribes it for diabetes?

Yes. Ozempic and Wegovy contain the same active ingredient (semaglutide) but are approved for different uses. Ozempic is approved for type 2 diabetes, and some Medicare plans cover it for that purpose. If you have type 2 diabetes and your doctor prescribes Ozempic, your plan may cover it even if they do not cover Wegovy. However, Ozempic and Wegovy are not interchangeable in terms of dosing or indication, so this decision must be made by your doctor.

What if I switch from original Medicare to a Medicare Advantage plan that covers Wegovy?

You can switch to a Medicare Advantage plan during the annual open enrollment period (October 15 to December 7 each year) or if you have a may have access to life event. Once you are enrolled in a plan that covers Wegovy, you can work with your doctor to start the medication. Keep in mind that Advantage plans can change their coverage from year to year, so confirm coverage before you enroll.

If I pay out of pocket for Wegovy now, will Medicare reimburse me later?

No. Medicare does not reimburse for drugs it does not cover, even if you pay for them yourself. If you are considering paying out of pocket, explore the manufacturer information programs and discount cards first, as they can significantly reduce your cost.

Does Medicare cover the doctor visits needed to prescribe and monitor Wegovy?

Yes. Original Medicare and Medicare Advantage both cover office visits with your doctor. If your doctor prescribes Wegovy and monitors your progress with regular appointments, those visits are covered. The medication itself is what may not be covered, not the medical care surrounding it.

What should I do if my plan denies coverage and my doctor says I need it?

Ask your doctor to submit an appeal on your behalf, explaining why Wegovy is medically necessary for your specific situation. Most plans have an appeals process that takes 30 to 60 days. Your doctor's documentation of your diagnosis, previous treatment attempts, and medical need strengthens the appeal. If the appeal is denied, ask whether your plan has an external review process, which is a second level of appeal.